Paint Therapeutics is an early-stage Biotech company that has developed novel peptide-drug conjugate technology for targeted delivery of partner’s drugs.
Paint has two platforms
(1) PulmoPaintTM - that delivers drugs targeted to the lungs
(2) SystemoPulseTM - that delivers drugs to the systemic circulation via the lungs, as an alternative to traditional oral route.
Address
AtlantaGeorgia
United States
